Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease

Molecules and Cells

Volumn 38, Issue 4, 2015, Pages 285-296

  Gorin, Yves ^a   Wauquier, Fabien ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Diabetic nephropathy; Downstream effectors of Nox NADPH oxidases; Nox family of NADPH oxidases; Oxidative stress; Upstream regulators of Nox NADPH oxidases

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DAMAGE; DIABETIC NEPHROPATHY; ENZYME REGULATION; HUMAN; HYPERGLYCEMIA; LEYDIG CELL; MESANGIUM CELL; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PODOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; DIABETIC NEPHROPATHIES; ENZYMOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; MOLECULAR TARGETED THERAPY; NADPH OXIDASE; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84944726859     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2015.0010     Document Type: Article

References (167)

1. Abboud, H.E. (1997). Growth factors and diabetic nephrology: an overview. Kidney Int. Supplement 60, S3-6.
2. Ago, T., Kuroda, J., Pain, J., Fu, C., Li, H., and Sadoshima, J. (2010). Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ. Res. 106, 1253-1264.
3. Altenhofer, S., Kleikers, P.W., Radermacher, K.A., Scheurer, P., Rob Hermans, J.J., Schiffers, P., Ho, H., Wingler, K., and Schmidt, H.H. (2012). The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell. Mol. Life Sci. 69, 2327-2343.
4. Aoyama, T., Paik, Y.H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., Molango, S., Heitz, F., Merlot, C., Szyndralewiez, C., et al. (2012). Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology 56, 2316-2327.
5. Asaba, K., Tojo, A., Onozato, M.L., Goto, A., Quinn, M.T., Fujita, T., and Wilcox, C.S. (2005). Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int. 67, 1890-1898.
6. Barnes, J.L., and Gorin, Y. (2011). Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int. 79, 944-956.
7. Baynes, J.W. (1991). Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412.
8. Bedard, K., and Krause, K.H. (2007). The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245-313.
9. Block, K., Eid, A., Griendling, K.K., Lee, D.Y., Wittrant, Y., and Gorin, Y. (2008). Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J. Biol. Chem. 283, 24061-24076.
10. Block, K., Gorin, Y., and Abboud, H.E. (2009). Subcellular localization of Nox4 and regulation in diabetes. Proc. Natl. Acad. Sci. USA 106, 14385-14390.
11. Block, K., Ricono, J.M., Lee, D.Y., Bhandari, B., Choudhury, G.G., Abboud, H.E., and Gorin, Y. (2006). Arachidonic acid-dependent activation of a p22(phox)-based NAD(P)H oxidase mediates angiotensin Il-induced mesangial cell protein synthesis and fibronectin expression via Akt/PKB. Antioxid. Redox Signal. 8, 1497-1508.
12. Bondi, C.D., Manickam, N., Lee, D.Y., Block, K., Gorin, Y., Abboud, H.E., and Barnes, J.L. (2010). NaD(P)H oxidase mediates TGF- beta1-induced activation of kidney myofibroblasts. J. Am. Soc. Nephrol. 21, 93-102.
13. Brandes, R.P., and Schroder, K. (2008). Composition and functions of vascular nicotinamide adenine dinucleotide phosphate oxidases. Trends Cardiovasc. Med. 18, 15-19.
14. Brandes, R.P., Weissmann, N., and Schroder, K. (2010). NADPH oxidases in cardiovascular disease. Free Radic. Bio. Med. 49, 687-706.
15. Brown, D.I., and Griendling, K.K. (2009). Nox proteins in signal transduction. Free Radic. Bio. Med. 47, 1239-1253.
16. Brownlee, M. (2005). The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615-1625.
17. Campbell, K.N., Raij, L., and Mundel, P. (2011). Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Curr. Diabetes Rev. 7, 3-7.
18. Carnesecchi, S., Deffert, C., Donati, Y., Basset, O., Hinz, B., Preynat-Seauve, O., Guichard, C., Arbiser, J.L., Banfi, B., Pache, J.C., et al. (2011). A key role for NOX4 in epithelial cell death during development of lung fibrosis. Antioxid. Redox Signal. 15, 607-619.
19. Chai, D., Wang, B., Shen, L., Pu, J., Zhang, X.K., and He, B. (2008). RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells. Free Radic. Bio. Med. 44, 1334-1347.
20. Chen, J., Chen, J.K., and Harris, R.C. (2012). Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway. Mol. Cell. Biol. 32, 981-991.
21. Clempus, R.E., Sorescu, D., Dikalova, A.E., Pounkova, L., Jo, P., Sorescu, G.P., Schmidt, H.H., Lassegue, B., and Griendling, K.K. (2007). Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 27, 42-48.
22. Coughlan, M.T., Thorburn, D.R., Penfold, S.A., Laskowski, A., Harcourt, B.E., Sourris, K.C., Tan, A.L., Fukami, K., Thallas- Bonke, V., Nawroth, P.P., et al. (2009). RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J. Am. Soc. Nephrol. 20, 742-752.
23. Craven, P.A., Phillips, S.L., Melhem, M.F., Liachenko, J., and DeRubertis, F.R. (2001). Overexpression of manganese superoxide dismutase suppresses increases in collagen accumulation induced by culture of mesangial cells in high-media glucose. Metabolism 50, 1043-1048.
24. Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P.J., Ariyan, S., Dikalov, S., and Sorescu, D. (2005). nAd(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 97, 900-907.
25. Das, R., Xu, S., Quan, X., Nguyen, T.T., Kong, I.D., Chung, C.H., Lee, E.Y., Cha, S.K., and Park, K.S. (2014). Upregulation of mitochondrial Nox4 mediates TGF-beta-induced apoptosis in cultured mouse podocytes. Am. J. Physiol. Renal Physiol. 306, F155-167.
26. de Mochel, N.S., Seronello, S., Wang, S.H., Ito, C., Zheng, J.X., Liang, T.J., Lambeth, J.D., and Choi, J. (2010). Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology 52, 47-59.
27. Di Marco, E., Gray, S.P., Chew, P., Koulis, C., Ziegler, A., Szyndralewiez, C., Touyz, R.M., Schmidt, H.H., Cooper, M.E., Slattery, R., et al. (2014). Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune- inflammatory responses in diabetic Apoe(-/-) mice. Diabetologia 57, 633-642.
28. Diaz, B., Shani, G., Pass, I., Anderson, D., Quintavalle, M., and Courtneidge, S.A. (2009). Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Sci. Signal. 2, ra53.
29. Dikalov, S. (2011). Cross talk between mitochondria and NADPH oxidases. Free Radic. Biol. Med. 51, 1289-1301.
30. Ding, G., Zhang, A., Huang, S., Pan, X., Zhen, G., Chen, R., and Yang, T. (2007). ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox- sensitive transactivation of the EGFR. Am. J. Physiol. Renal. Physiol. 293, F1889-1897.
31. Drummond, G.R., Selemidis, S., Griendling, K.K., and Sobey, C.G. (2011). Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. 10, 453-471.
32. Eid, A.A., Gorin, Y., Fagg, B.M., Maalouf, R., Barnes, J.L., Block, K., and Abboud, H.E. (2009). Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 58, 1201-1211.
33. Eid, A.A., Ford, B.M., Block, K., Kasinath, B.S., Gorin, Y., Ghosh- Choudhury, G., Barnes, J.L., and Abboud, H.E. (2010). AMP- activated protein kinase (AMPK) negatively regulates Nox4- dependent activation of p53 and epithelial cell apoptosis in diabetes. J. Biol. Chem. 285, 37503-37512.
34. Eid, A.A., Ford, B.M., Bhandary, B., de Cassia Cavaglieri, R., Block, K., Barnes, J.L., Gorin, Y., Choudhury, G.G., and Abboud, H.E. (2013a). Mammalian target of rapamycin regulates Nox4- mediated podocyte depletion in diabetic renal injury. Diabetes 62, 2935-2947.
35. Eid, A.A., Lee, D.Y., Roman, L.J., Khazim, K., and Gorin, Y. (2013b). Sestrin 2 and AmPk connect hyperglycemia to Nox4- dependent endothelial nitric oxide synthase uncoupling and matrix protein expression. Mol. Cell. Biol. 33, 3439-3460.
36. Etoh, T., Inoguchi, T., Kakimoto, M., Sonoda, N., Kobayashi, K., Kuroda, J., Sumimoto, H., and Nawata, H. (2003). Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia 46, 1428-1437.
37. Forbes, J.M., Coughlan, M.T., and Cooper, M.E. (2008). Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57, 1446-1454.
38. Ford, B.M., Eid, A.A., Gooz, M., Barnes, J.L., Gorin, Y.C., and Abboud, H.E. (2013). ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice. Am. J. Physiol. Renal. Physiol. 305, F323-332.
39. Fu, Y., Zhang, Y., Wang, Z., Wang, L., Wei, X., Zhang, B., Wen, Z., Fang, H., Pang, Q., and Yi, F. (2010). Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy. Am. J. Nephrol. 32, 581-589.
40. Fujii, M., Inoguchi, T., Maeda, Y., Sasaki, S., Sawada, F., Saito, R., Kobayashi, K., Sumimoto, H., and Takayanagi, R. (2007). Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice. Kidney Int. 72, 473-480.
41. Fujii, M., Inoguchi, T., Sasaki, S., Maeda, Y., Zheng, J., Kobayashi, K., and Takayanagi, R. (2010). Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. Kidney Int. 78, 905-919.
42. Gaggini, F., Laleu, B., Orchard, M., Fioraso-Cartier, L., Cagnon, L., Houngninou-Molango, S., Gradia, A., Duboux, G., Merlot, C., Heitz, F., et al. (2011). Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors. Bioorg. Med. Chem. 19, 6989-6999.
43. Geiszt, M. (2006). NADPH oxidases: new kids on the block. Cardiov. Res. 71, 289-299.
44. Geiszt, M., Kopp, J.B., Varnai, P., and Leto, T.L. (2000). Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. USA 97, 8010-8014.
45. Giacco, F., and Brownlee, M. (2010). Oxidative stress and diabetic complications. Circ. Res. l07, 1058-1070.
46. Gill, P.S. and Wilcox, C.S. (2006). NADPH oxidases in the kidney. Antioxid. Redox Signal. 8, 1597-1607.
47. Gojo, A., Utsunomiya, K., Taniguchi, K., Yokota, T., Ishizawa, S., Kanazawa, Y., Kurata, H., and Tajima, N. (2007). The Rhokinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 568, 242-247.
48. Gorin, Y., and Block, K. (2013a). Nox4 and diabetic nephropathy: With a friend like this, who needs enemies? Free Radic. Biol. Med. 61C, 130-142.
49. Gorin, Y., and Block, K. (2013b). Nox as a target for diabetic complications. Clin. Sci (Lond) 125, 361-382.
50. Gorin, Y., Block, K., Hernandez, J., Bhandari, B., Wagner, B., Barnes, J.L., and Abboud, H.E. (2005). Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J. Biol. Chem. 280, 39616-39626.
51. Gorin, Y., Ricono, J.M., Kim, N.H., Bhandari, B., Choudhury, G.G., and Abboud, H.E. (2003). Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am. J. Physiol. Renal Physiol. 285, F219-229.
52. Gorin, Y., Ricono, J.M., Wagner, B., Kim, N.H., Bhandari, B., Choudhury, G.G., and Abboud, H.E. (2004). Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox- dependent in glomerular mesangial cells. Biochem. J. 381, 231-239.
53. Gray, S.P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A.C., de Haan, J.B., Koulis, C., El-Osta, A., Andrews, K.L., et al. (2013). NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation 127, 1888-1902.
54. Greiber, S., Munzel, T., Kastner, S., Muller, B., Schollmeyer, P., and Pavenstadt, H. (1998). NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate. Kidney Int. 53, 654-663.
55. Griendling, K.K., and FitzGerald, G.A. (2003). Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108, 1912-1916.
56. Hannken, T., Schroeder, R., Stahl, R.A., and Wolf, G. (1998). Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. Kidney Int. 54, 1923-1933.
57. Hecker, L., Logsdon, N.J., Kurundkar, D., Kurundkar, A., Bernard, K., Hock, T., Meldrum, E., Sanders, Y.Y., and Thannickal, V.J. (2014). Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci. Trans. Med. 6, 231ra247.
58. Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T.R., Horowitz, J.C., Pennathur, S., Martinez, F.J., and Thannickal, V.J. (2009). NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 15, 1077-1081.
59. Hinokio, Y., Suzuki, S., Hirai, M., Chiba, M., Hirai, A., and Toyota, T. (1999). Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 42, 995-998.
60. Holterman, C.E., Thibodeau, J.F., Towaij, C., Gutsol, A., Montezano, A. C., Parks, R.J., Cooper, M.E., Touyz, R.M., and Kennedy, C.R. (2014). Nephropathy and elevated BP in mice with podocyte- specific NADPH oxidase 5 expression. J. Am. Soc. Nephrol. 25, 784-797.
61. 2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells. J. Biol. Chem. 278, 33951-33962.
62. Hwang, I., Lee, J., Huh, J.Y., Park, J., Lee, H.B., Ho, Y.S., and Ha, H. (2012). Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes 61, 728-738.
63. Ito, N., Ruegg, U.T., Kudo, A., Miyagoe-Suzuki, Y., and Takeda, S. (2013). Activation of calcium signaling through Trpv1 by nNOS and peroxynitrite as a key trigger of skeletal muscle hypertrophy. Nat. Med. 19, 101-106.
64. Jaquet, V., Scapozza, L., Clark, R.A., Krause, K.H., and Lambeth, J.D. (2009). Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid. Redox Signal. 11, 2535-2552.
65. Jeong, S.I., Kim, S.J., Kwon, T.H., Yu, K.Y., and Kim, S.Y. (2012). Schizandrin prevents damage of murine mesangial cells via blocking NADPH oxidase-induced ROS signaling in high glucose. Food Chem. Toxicol. 50, 1045-1053.
66. Jha, J.C., Gray, S.P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F., et al. (2014). Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J. Am. Soc. Nephrol. 25, 1237-1254.
67. Jiang, J.X., Chen, X., Serizawa, N., Szyndralewiez, C., Page, P., Schroder, K., Brandes, R.P., Devaraj, S., and Torok, N.J. (2012). Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic. Biol. Med. 53, 289-296.
68. Jones, S.A., Hancock, J.T., Jones, O.T., Neubauer, A., and Topley, N. (1995). The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox. J. Am. Soc. Nephrol. 5, 1483-1491.
69. Kanwar, Y.S., Sun, L., Xie, P., Liu, F.Y., and Chen, S. (2011). A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Ann. Rev. Pathol. 6, 395-423.
70. Kanwar, Y.S., Wada, J., Sun, L., Xie, P., Wallner, E.I., Chen, S., Chugh, S., and Danesh, F.R. (2008). Diabetic nephropathy: mechanisms of renal disease progression. Exp. Biol. Med. 233, 4-11.
71. Kashihara, N., Haruna, Y., Kondeti, V.K., and Kanwar, Y.S. (2010). Oxidative stress in diabetic nephropathy. Curr. Med. Chem. 17, 4256-4269.
72. Khazim, K., Gorin, Y., Cavaglieri, R.C., Abboud, H.E., and Fanti, P. (2013). The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo. Am. J. Physiol. Renal Physiol. 305, F691-700.
73. Kim, J.A., Neupane, G.P., Lee, E.S., Jeong, B.S., Park, B.C., and Thapa, P. (2011). NADPH oxidase inhibitors: a patent review. Expert Opin. Ther. Pat. 21, 1147-1158.
74. Kim, S.M., Kim, Y.G., Jeong, K.H., Lee, S.H., Lee, T.W., Ihm, C.G., and Moon, J.Y. (2012). Angiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cells. PLoS One 7, e39739.
75. Kiritoshi, S., Nishikawa, T., Sonoda, K., Kukidome, D., Senokuchi, T., Matsuo, T., Matsumura, T., Tokunaga, H., Brownlee, M., and Araki, E. (2003). Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 52, 2570-2577.
76. Kitada, M., Koya, D., Sugimoto, T., Isono, M., Araki, S., Kashiwagi, A., and Haneda, M. (2003). Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 52, 2603-2614.
77. Kitada, M., Kume, S., Imaizumi, N., and Koya, D. (2011). Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 60, 634-643.
78. Koya, D., Hayashi, K., Kitada, M., Kashiwagi, A., Kikkawa, R., and Haneda, M. (2003). Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J. Am. Soc. Nephrol. 14, S250-253.
79. Koziel, R., Pircher, H., Kratochwil, M., Lener, B., Hermann, M., Dencher, N.A., and Jansen-Durr, P. (2013). Mitochondrial respiratory chain complex I is inactivated by NADPH oxidase Nox4. Biochem. J. 452, 231-239.
80. Kuroda, J., Nakagawa, K., Yamasaki, T., Nakamura, K., Takeya, R., Kuribayashi, F., Imajoh-Ohmi, S., Igarashi, K., Shibata, Y., Sueishi, K., et al. (2005). The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 10, 1139-1151.
81. Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M.D., and Sadoshima, J. (2010). NADPH oxidase 4 (Nox4). is a major source of oxidative stress in the failing heart. Proc. Natl. Acad. Sci. USA 107, 15565-15570.
82. Kwan, J., Wang, H., Munk, S., Xia, L., Goldberg, H.J., and Whiteside, C.I. (2005). In high glucose protein kinase C-zeta activation is required for mesangial cell generation of reactive oxygen species. Kidney Int. 68, 2526-2541.
83. Laleu, B., Gaggini, F., Orchard, M., Fioraso-Cartier, L., Cagnon, L., Houngninou-Molango, S., Gradia, A., Duboux, G., Merlot, C., Heitz, F., et al. (2010). First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4). inhibitors for the treatment of idiopathic pulmonary fibrosis. J. Med. Chem. 53, 7715-7730.
84. Lambeth, J.D. (2007). Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic. Biol. Med. 43, 332-347.
85. Lambeth, J.D., Kawahara, T., and Diebold, B. (2007). Regulation of Nox and Duox enzymatic activity and expression. Free Radic. Biol. Med. 43, 319-331.
86. Lambeth, J.D., Krause, K.H., and Clark, R.A. (2008). NOX enzymes as novel targets for drug development. Semin. Immunopathol. 30, 339-363.
87. Lassegue, B., and Clempus, R.E. (2003). Vascular NAD(P).H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R277-297.
88. Lassegue, B., and Griendling, K.K. (2010). NADPH oxidases: functions and pathologies in the vasculature. Arterioscler. Thromb. Vasc. Biol. 30, 653-661.
89. Lassegue, B., Sorescu, D., Szocs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S.L., Lambeth, J.D., and Griendling, K.K. (2001). Novel gp91(phox). homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88, 888-894.
90. Lassegue, B., San Martin, A. and Griendling, K.K. (2012). Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ. Res. 110, 1364-1390.
91. Lavrentyev, E.N., and Malik, K.U. (2009). High glucose-induced Nox1-derived superoxides downregulate PKC-betaII, which subsequently decreases ACE2 expression and ANG(1-7). formation in rat VSMCs. Am. J. Physiol. Heart Circ. Physiol. 296, H106-118.
92. Lee, H.B., Yu, M.R., Yang, Y., Jiang, Z. and Ha, H. (2003). Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J. Am. Soc. Nephrol. 14, S241-245.
93. Lee, D.Y., Wauquier, F., Eid, A.A., Roman, L.J., Ghosh-Choudhury, G, Khazim, K., Block, K., and Gorin, Y. (2013a). Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: role of mitochondrial reactive oxygen species. J. Biol. Chem. 288, 28668-28686.
94. Lee, J.H., Kim, J.H., Kim, J.S., Chang, J.W., Kim, S.B., Park, J.S. and Lee, S.K. (2013b). AMP-activated protein kinase inhibits TGF-beta-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition. Am. J. Physiol. Renal Physiol. 304, F686-697.
95. Liu, G.C., Fang, F., Zhou, J., Koulajian, K., Yang, S., Lam, L., Reich, G. N., John, R., Herzenberg, A.M., Giacca, A., et al. (2012). Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse. Diabetologia 55, 2522-2532.
96. Liu, R.M., Choi, J., Wu, J.H., Gaston Pravia, K.A., Lewis, K.M., Brand, J.D., Mochel, N.S., Krzywanski, D.M., Lambeth, J.D., Hagood, J.S., et al. (2010). Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J. Biol. Chem. 285, 16239-16247.
97. Lyle, A.N., Deshpande, N.N., Taniyama, Y., Seidel-Rogol, B., Pounkova, L., Du, P., Papaharalambus, C., Lassegue, B. and Griendling, K.K. (2009). Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ. Res. 105, 249-259.
98. Maalouf, R.M., Eid, A.A., Gorin, Y.C., Block, K., Escobar, G.P., Bailey, S., and Abboud, H.E. (2012). Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes. Am. J. Physiol. Cell Physiol. 302, C597-604.
99. Maeda, Y., Inoguchi, T., Takei, R., Sawada, F., Sasaki, S., Fujii, M., Kobayashi, K., Urata, H., Nishiyama, A., and Takayanagi, R. (2010). Inhibition of chymase protects against diabetes-induced oxidative stress and renal dysfunction in hamsters. Am. J. Physiol. Renal Physiol. 299, F1328-1338.
100. Mahadev, K., Motoshima, H., Wu, X., Ruddy, J.M., Arnold, R.S., Cheng, G., Lambeth, J.D., and Goldstein, B.J. (2004). The NAD(P).H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 24, 1844-1854.
101. Manickam, N., Patel, M., Griendling, K.K., Gorin, Y., and Barnes, J.L. (2014). RhoA/Rho kinase mediates TGF-beta1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species. Am. J. Physiol. Renal Physiol. 307, F159-171.
102. McCarty, M.F., Barroso-Aranda, J., and Contreras, F. (2009). AMP- activated kinase may suppress NADPH oxidase activation in vascular tissues. Med. Hypotheses 72, 468-470.
103. Meng, D., Lv, D.D., and Fang, J. (2008). Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells. Cardiov. Res. 80, 299-308.
104. Menini, S., Iacobini, C., Ricci, C., Oddi, G., Pesce, C., Pugliese, F., Block, K., Abboud, H.E., Giorgio, M., Migliaccio, E., et al. (2007). Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation. Diabetologia 50, 1997-2007.
105. Mittal, M., Roth, M., Konig, P., Hofmann, S., Dony, E., Goyal, P., Selbitz, A.C., Schermuly, R.T., Ghofrani, H.A., Kwapiszewska, G., et al. (2007). Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ. Res. 101, 258-267.
106. Miyata, K., Rahman, M., Shokoji, T., Nagai, Y., Zhang, G.X., Sun, G. P., Kimura, S., Yukimura, T., Kiyomoto, H., Kohno, M., et al. (2005). Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J. Am. Soc. Nephrol. 16, 2906-2912.
107. Moe, K.T., Aulia, S., Jiang, F., Chua, Y.L., Koh, T.H., Wong, M.C. and Dusting, G.J. (2006). Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells. J. Cell. Mol. Med. 10, 231-239.
108. New, D.D., Block, K., Bhandhari, B., Gorin, Y., and Abboud, H.E. (2001). IGF-I increases the expression of fibronectin by Nox4- dependent Akt phosphorylation in renal tubular epithelial cells. Am. J. Physiol. Renal Physiol. 302, C122-130.
109. Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M.A., Beebe, D., Oates, P.J., Hammes, G. P. et al. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787-790.
110. Nistala, R., Whaley-Connell, A., and Sowers, J.R. (2008). Redox control of renal function and hypertension. Antioxid. Redox Signal. 10, 2047-2089.
111. Octavia, Y., Brunner-La Rocca, H.P., and Moens, A.L. (2012). NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach. Free Radic. Biol. Med. 52, 291-297.
112. Ohshiro, Y., Ma, R.C., Yasuda, Y., Hiraoka-Yamamoto, J., Clermont, A.C., Isshiki, K., Yagi, K., Arikawa, E., Kern, T.S., and King, G.L. (2006). Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Diabetes 55, 3112-3120.
113. Papadimitriou, A., Peixoto, E.B., Silva, K.C., Lopes de Faria, J.M., and Lopes de Faria, J.B. (2014). Increase in AMPK brought about by cocoa is renoprotective in experimental diabetes mellitus by reducing NOX4/TGFbeta-1 signaling. J. Nutr. Biochem. 25, 773-784.
114. Paravicini, T.M., and Touyz, R.M. (2008). NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31 Suppl 2, S170-180.
115. Pedruzzi, E., Guichard, C., Ollivier, V., Driss, F., Fay, M., Prunet, C., Marie, J.C., Pouzet, C., Samadi, M., Elbim, C., et al. (2004). NAD(P).H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol. Cell. Biol. 24, 10703-10717.
116. Peng, Z.Z., Hu, G.Y., Shen, H., Wang, L., Ning, W.B., Xie, Y.Y., Wang, N.S., Li, B.X., Tang, Y.T., and Tao, L.J. (2009). Fluorofenidone attenuates collagen I and transforming growth factor-beta1 expression through a nicotinamide adenine dinucleotide phosphate oxidase-dependent way in NRK-52E cells. Nephrology 14, 565-572.
117. Peshavariya, H., Jiang, F., Taylor, C.J., Selemidis, S., Chang, C.W., and Dusting, G.J. (2009). Translation-linked mRNA destabilization accompanying serum-induced Nox4 expression in human endothelial cells. Antioxid. Redox Signal. 11, 2399-2408.
118. Peshavariya, H.M., Dusting, G.J. and Selemidis, S. (2007). Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase. Free Radic. Res. 41, 699-712.
119. Piwkowska, A., Rogacka, D., Audzeyenka, I., Jankowski, M., and Angielski, S. (2011). High glucose concentration affects the oxidant-antioxidant balance in cultured mouse podocytes. J. Cell. Biochem. 112, 1661-1672.
120. Piwkowska, A., Rogacka, D., Jankowski, M., Dominiczak, M.H., Stepinski, J.K. and Angielski, S. (2010). Metformin induces suppression of NAD(P).H oxidase activity in podocytes. Biochem. Biophys. Res. Commun. 393, 268-273.
121. Pleskova, M., Beck, K.F., Behrens, M.H., Huwiler, A., Fichtlscherer, A., Wingerter, O., Brandes, R.P., Mulsch, A. and Pfeilschifter, J. (2005). Nitric oxide down-regulates the expression of the catalytic NADPH oxidase subunit Nox1 in rat renal mesangial cells. FASEB J. 20, 139-141.
122. Rhyu, D.Y., Yang, Y., Ha, H., Lee, G.T., Song, J.S., Uh, S.T. and Lee, H.B. (2005). Role of reactive oxygen species in TGF-beta1- induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J. Am. Soc. Nephrol. 16, 667-675.
123. Rincon-Choles, H., Kasinath, B.S., Gorin, Y. and Abboud, H.E. (2002). Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy. Kidney Int. Supplement S8-11.
124. Rivera, J., Sobey, C.G., Walduck, A.K. and Drummond, G.R. (2010). Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. Redox Rep. 15, 50-63.
125. Schnackenberg, C.G. (2002). Oxygen radicals in cardiovascular- renal disease. Curr. Opin. Pharmacol. 2, 121-125.
126. Schuhmacher, S., Foretz, M., Knorr, M., Jansen, T., Hortmann, M., Wenzel, P., Oelze, M., Kleschyov, A.L., Daiber, A., Keaney, J.F., Jr., et al. (2011). alpha1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation. Arterioscler. Thromb. Vasc. Biol. 31, 560-566.
127. Sedeek, M., Callera, G., Montezano, A., Gutsol, A., Heitz, F., Szyndralewiez, C., Page, P., Kennedy, C.R., Burns, K.D., Touyz, R.M., et al. (2010). Critical role of Nox4-based NaDpH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am. J. Physiol. Renal Physiol. 299, F1348-1358.
128. Sedeek, M., Gutsol, A., Montezano, A.C., Burger, D., Nguyen Dinh Cat, A., Kennedy, C.R., Burns, K.D., Cooper, M.E., Jandeleit- Dahm, K., Page, P., et al. (2013). Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. Clin. Sci. 124, 191-202.
129. Sedeek, M., Hebert, R.L., Kennedy, C.R., Burns, K.D. and Touyz, R.M. (2009). Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr. Opin. Nephrol. Hypertens. 18, 122-127.
130. Sedeek, M., Montezano, A.C., Hebert, R.L., Gray, S.P., Di Marco, E., Jha, J.C., Cooper, M.E., Jandeleit-Dahm, K., Schiffrin, E.L., Wilkinson-Berka, J.L., et al. (2012). Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies. J. Cardiovasc. Transl. Res. 5, 509-518.
131. Selemidis, S., Sobey, C.G., Wingler, K., Schmidt, H.H., and Drummond, G.R. (2008). NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol. Ther. 120, 254-291.
132. Serrander, L., Cartier, L., Bedard, K., Banfi, B., Lardy, B., Plastre, O., Sienkiewicz, A., Forro, L., Schlegel, W., and Krause, K.H. (2005). NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem. J. 406, 105-114.
133. Shah, A., Xia, L., Goldberg, H., Lee, K.W., Quaggin, S.E., and Fantus, I.G. (2013). Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells. J. Biol. Chem. 288, 6835-6848.
134. Sharma, K., Ramachandrarao, S., Qiu, G., Usui, H.K., Zhu, Y., Dunn, S.R., Ouedraogo, R., Hough, K., McCue, P., Chan, L., et al. (2008). Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest. 118, 1645-1656.
135. Shiose, A., Kuroda, J., Tsuruya, K., Hirai, M., Hirakata, H., Naito, S., Hattori, M., Sakaki, Y., and Sumimoto, H. (2001). A novel superoxide-producing NAD(P).H oxidase in kidney. J. Biolo. Chem. 276, 1417-1423.
136. Singh, D.K., Winocour, P., and Farrington, K. (2011). Oxidative stress in early diabetic nephropathy: fueling the fire. Nat. Rev. 7, 176-184.
137. Siu, K.L., Lotz, C., Ping, P., and Cai, H. (2015). Netrin-1 abrogates ischemia/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS. J. Mol. Cell Cardiol. 78, 174-185.
138. Son, S.M., Whalin, M.K., Harrison, D.G., Taylor, W.R., and Griendling, K.K. (2004). Oxidative stress and diabetic vascular complications. Curr. Diabetes Rep. 4, 247-252.
139. Sonta, T., Inoguchi, T., Matsumoto, S., Yasukawa, K., Inuo, M., Tsubouchi, H., Sonoda, N., Kobayashi, K., Utsumi, H., and Nawata, H. (2005). In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker. Biochem. Biophys. Res. Commun. 330, 415-422.
140. Stanton, R.C. (2011). Oxidative stress and diabetic kidney disease. Curr. Diabetes Rep. 11, 330-336.
141. Sturrock, A., Cahill, B., Norman, K., Huecksteadt, T.P., Hill, K., Sanders, K., Karwande, S.V., Stringham, J.C., Bull, D.A., Gleich, M., et al. (2006). Transforming growth factor-beta1 induces Nox4 NAD(P).H oxidase and reactive oxygen species- dependent proliferation in human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L661-L673.
142. Takac, I., Schroder, K., Zhang, L., Lardy, B., Anilkumar, N., Lambeth, J.D., Shah, A.M., Morel, F. and Brandes, R.P. (2011). The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J. Biol. Chem. 286, 13304-13313.
143. Takao, T., Horino, T., Kagawa, T., Matsumoto, R., Shimamura, Y., Ogata, K., Inoue, K., Taniguchi, Y., Taguchi, T., Morita, T., et al. (2010). Possible involvement of intracellular angiotensin II receptor in high-glucose-induced damage in renal proximal tubular cells. J. Nephrol. 24, 218-224.
144. Thallas-Bonke, V., Thorpe, S.R., Coughlan, M.T., Fukami, K., Yap, F. Y., Sourris, K.C., Penfold, S.A., Bach, L.A., Cooper, M.E. and Forbes, J.M. (2008). Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 57, 460-469.
145. Thallas-Bonke, V., Jha, J.C., Gray, S.P., Barit, D., Haller, H., Schmidt, H.H., Coughlan, M.T., Cooper, M.E., Forbes, J.M. and Jandeleit-Dahm, K.A. (2014). Nox-4 deletion reduces oxidative stress and injury by PKC-alpha-associated mechanisms in diabetic nephropathy. Physiol. Rep. 2 pii: e1219.
146. Ushio-Fukai, M. (2006). Localizing NADPH oxidase-derived ROS. Sci. STKE 2006, re8.
147. Varga, Z.V., Kupai, K., Szucs, G., Gaspar, R., Paloczi, J., Farago, N., Zvara, A., Puskas, L.G., Razga, Z., Tiszlavicz, L., et al. (2011). MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart. J. Mol. Cell. Cardiol. 62, 111-121.
148. Vasavada, N., and Agarwal, R. (2005). Role of oxidative stress in diabetic nephropathy. Adv. Chronic. Kidney Dis. 12, 146-154.
149. Vendrov, A.E., Madamanchi, N.R., Niu, X.L., Molnar, K.C., Runge, M., Szyndralewiez, C., Page, P., and Runge, M.S. (2010). NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis. J. Biol. Chem. 285, 26545-26557.
150. Wang, S., Zhang, M., Liang, B., Xu, J., Xie, Z., Liu, C., Viollet, B., Yan, D., and Zou, M.H. (2010). AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ. Res. 106, 1117-1128.
151. Wei, X.F., Zhou, Q.G., Hou, F.F., Liu, B.Y., and Liang, M. (2009). Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am. J. Physiol. Renal Physiol. 296, F427-437.
152. Whaley-Connell, A., Habibi, J., Nistala, R., Cooper, S.A., Karuparthi, P.R., Hayden, M.R., Rehmer, N., DeMarco, V.G., Andresen, A. T., Wei, Y., et al. (2008). Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Hypertension 51, 474-480.
153. Whiteside, C., Wang, H., Xia, L., Munk, S., Goldberg, H.J., and Fantus, I.G. (2009). Rosiglitazone prevents high glucose- induced vascular endothelial growth factor and collagen IV expression in cultured mesangial cells. Exp. Diabetes Res. 2009, 910783.
154. Wilkinson-Berka, J.L., Deliyanti, D., Rana, I., Miller, A.G., Agrotis, A., Armani, R., Szyndralewiez, C., Wingler, K., Touyz, R.M., Cooper, M.E., et al. (2014). NADPH oxidase, NoX1, mediates vascular injury in ischemic retinopathy. Antioxid. Redox Signal. 20, 2726-2740.
155. Williams, C.R. and Gooch, J.L. (2014). Calcineurin Abeta regulates NADPH oxidase (Nox). expression and activity via nuclear factor of activated T cells (NFAT) in response to high glucose. J. Biol. Chem. 289, 4896-4905.
156. Wingler, K., Wunsch, S., Kreutz, R., Rothermund, L., Paul, M., and Schmidt, H.H. (2001). Upregulation of the vascular NAD(P)H- oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic. Biol. Med. 31, 1456-1464.
157. Wu, R.F., Ma, Z., Myers, D.P., and Terada, L.S. (2007). HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK Map kinases. J. Biol. Chem. 282, 37412-37419.
158. Xia, L., Wang, H., Goldberg, H.J., Munk, S., Fantus, I.G., and Whiteside, C.I. (2006). Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression. Am. J. Physiol. Renal Physiol. 290, F345-356.
159. Xia, L., Wang, H., Munk, S., Kwan, J., Goldberg, H.J., Fantus, I.G., and Whiteside, C.I. (2008). High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells. Am. J. Physiol. Renal Physiol. 295, F1705-1714.
160. Xu, Y., Ruan, S., Xie, H., and Lin, J. (2010). Role of LOX-1 in Ang II-induced oxidative functional damage in renal tubular epithelial cells. Int. J. Mol. Med. 26, 679-690.
161. Yamagishi, S., Nakamura, K., Ueda, S., Kato, S., and Imaizumi, T. (2005). Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res. 320, 437-445.
162. You, Y.H., Okada, S., Ly, S., Jandeleit-Dahm, K., Barit, D., Namikoshi, T. and Sharma, K. (2013). Role of Nox2 in diabetic kidney disease. Am. J. Physiol. Renal Physiol. 304, F840-848.
163. Yu, L., Liu, Y., Wu, Y., Liu, Q., Feng, J., Gu, X., Xiong, Y., Fan, Q., and Ye, J. (2014a). Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside- induced podocyte damage. Cell. Signal. 26, 2979-2991.
164. Yu, P., Han, W., Villar, V.A., Yang, Y., Lu, Q., Lee, H., Li, F., Quinn, M.T., Gildea, J.J., Felder, R.A., et al. (2014b). Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells. Redox Biol. 2, 570-579.
165. Zhang, H., Jiang, Z., Chang, J., Li, X., Zhu, H., Lan, H.Y., Zhou, S.F., and Yu, X. (2009). Role of NaD(P).H oxidase in transforming growth factor-beta1-induced monocyte chemo- attractant protein-1 and interleukin-6 expression in rat renal tubular epithelial cells. Nephrology 14, 302-310.
166. Zhang, L., Pang, S., Deng, B., Qian, L., Chen, J., Zou, J., Zheng, J., Yang, L., Zhang, C., Chen, X., et al. (2012). High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-kappaB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol. Int. J. Biochem. Cell Biol. 44, 629-638.
167. Ziyadeh, F.N., and Wolf, G. (2008) Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr. Diabetes Rev. 4, 39-45.